Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy

This study has been withdrawn prior to enrollment.
(No participants enrolled)
Sponsor:
Information provided by:
Kettering Health Network
ClinicalTrials.gov Identifier:
NCT01045044
First received: January 6, 2010
Last updated: April 4, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: October 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)